Benefits
Better Bioavailability vs Fish Oil (Phospholipid Form)
EPA and DHA in krill oil are bound to phospholipids rather than to the triglycerides found in fish oil. The single reference on this page is a double-blind randomized crossover trial in 24 healthy volunteers, 600 mg of n-3 PUFA per treatment, 4 weeks per phase with an 8-week washout. Krill oil raised the omega-3 index in plasma and red blood cells more than fish oil did. The omega-3 index is a blood biomarker of omega-3 status, not a health outcome, and whether that difference allows a lower effective dose was not tested.
Improved GI Tolerability
Uncited on this page. The one reference here measured the omega-3 index only and did not record reflux, aftertaste or digestive symptoms. Better tolerability is a widely reported user impression, not a finding from the evidence cited.
Triglyceride Reduction
Uncited on this page. The lipid results described here come from a trial card with no reference attached, so none of them can be checked against a source. The one cited study measured the omega-3 index, a surrogate blood marker, and did not measure triglycerides or any other lipid or cardiovascular outcome.
Astaxanthin Co-Delivery
Krill oil naturally contains astaxanthin, the red carotenoid that gives krill their color, and it helps protect the oil from oxidation. No reference on this page measured astaxanthin content, antioxidant status, or any skin or eye outcome. Astaxanthin content varies by product, and the figures commonly quoted for it are not verified by anything cited here.
Joint Comfort (Not Supported by the Evidence Cited Here)
No trial of joint pain appears among the references on this page, and nothing cited here measured any joint outcome. Joint comfort should be treated as unsupported by the evidence listed on this page.
Menstrual Comfort (Not Supported by the Evidence Cited Here)
No such trial appears among the references on this page, and nothing cited here measured menstrual symptoms. The prostaglandin explanation is a proposed mechanism rather than a result from any study listed here.
Mechanism of action
Phospholipid vs Triglyceride EPA/DHA
In krill oil, EPA and DHA are esterified to phospholipid backbone (mostly phosphatidylcholine) — vs triglyceride backbone in fish oil. Phospholipid-bound omega-3s are absorbed via different pathway — better pancreatic lipase digestion, formation of mixed micelles, possibly direct lymphatic uptake. Result: higher omega-3 index per gram of EPA/DHA consumed.
Astaxanthin Antioxidant Activity
Astaxanthin (the red carotenoid that gives krill/salmon their color) is commonly described as having stronger antioxidant activity than other carotenoids, and it is active in both lipid and water phases. It protects krill oil from oxidation. No study cited on this page measured antioxidant status or any health effect of astaxanthin in people.
Choline Co-Delivery
Phosphatidylcholine in krill oil provides ~14% choline by weight — modest choline supplementation alongside omega-3s.
Same Underlying Omega-3 Mechanisms
Once absorbed, EPA and DHA from krill oil have same fundamental mechanisms as from fish oil — eicosanoid modulation, membrane composition, etc.
Clinical trials
Reported as a trial of krill oil (1-3 g/day) versus fish oil versus placebo in 120 people with high blood lipids over 90 days. Uncited: no reference on this page supports this card, so the design, the participant count, the duration and the results below cannot be traced to a source. The people described were also a clinical population with diagnosed high blood lipids rather than general users.
Reported as 120 people with high blood lipids. Uncited, so the number cannot be verified.
Reported as lower total cholesterol, LDL and triglycerides and higher HDL. No reference is attached to this card, so none of those results can be verified, and nothing here establishes krill oil as an effective lipid intervention. Industry-sponsored study (limitation).
Double-blind randomized crossover trial comparing krill oil with fish oil at 600 mg of n-3 PUFA per treatment, 4 weeks per phase with an 8-week washout, measuring the omega-3 index in plasma and red blood cells.
24 healthy volunteers.
Krill oil produced a greater rise in the omega-3 index, measured in plasma and red blood cells, than fish oil. The omega-3 index is a blood biomarker of omega-3 status. No cardiovascular, lipid or other clinical outcome was measured, and 24 healthy volunteers over 4 weeks is a small, short comparison.